Reply  by Shimono, Takatsugu et al.
666 Letters to the Editor 
therapy and/or chemotherapy administered in the postopera-
tive period was followed by a significantly prolonged survival 
time (P = .023). Pulmonary metastases are present in up to 
60%4 of patients. Distal microembolization is common; 
therefore adjuvant therapy, even in the absence of pulmonary 
nodules, would seem appropriate. In conclusion, total surgi-
cal resection (which was best performed with the aid of car-
diopulmonary bypass through a median sternotomy), with the 
addition of chemotherapy, radiotherapy, or both, should offer 
these patients significant palliation and an opportunity for 
increased length of survival. 
Gerard Babatasi, MD, PhD" 
Massimo Massetti, MD" 
Franr;oise Galateau, MV 
Andre Khayat, MD" 
Department of Thoracic and Cardiovascular Surgery 
University Hospital 
CHU Caen, Francea 
Department of Cardiovascular Pathology 
CHU Caen and Armed Forces Institute of Pathology (AFIP) 
Washington, DCb 
REFERENCES 
1. Burke A, Virmani R. Tumors of the heart and great vessels. Vol 
16. Atlas of tumor pathology. Washington: Armed Forces Institute 
of Pathology; 1996. p. 127-69. 
2. Antunes MJ, Vanderdonck KM, Andrade CM, Rebelo LS. 
Primary cardiac leiomyosarcomas. Ann Thorac Surg 1991 ;51: 
999-1001. 
3. Fyfe AI, Huckell VF, Burr LH, Stonier PM. Leiomyosarcoma of 
the left atrium: case report and review of the literature. Can J 
CardioI1991;7:192-6. 
4. Anderson MB, Kriett JM, Kapelanski DP, Tarazi R, Jamieson 
SW. Primary pulmonary artery sarcoma: a report of 6 cases. Ann 
Thorac Surg 1995;59:1487-90. 
5. Kruger I, Borowski, A, Horst M, De Vivie ER, Theissen P, Gross-
Fengels W. Symptoms, diagnosis, and therapy of primary sarco-
mas of the pulmonary artery. Thorac Cardiovasc Surg 1990;38: 
91-5. 
6. Han P, Drachtman RA, Amenta P, Ettinger LJ. Successful treat-
ment of a primary cardiac leiomyosarcoma with Ifosfamide and 
Etoposide. J Pediatr Hematol OncoI1996;18:314-7. 
, 12/8/91860 
Reply to the Editor: 
We thank Babatasi, Massetti, Galateau, and Khayat for their 
interest in our article. We shall first respond to their comment 
that the tumor in the second case originated in the atrial wall 
and extended into the pulmonary vein. Because of space limi-
tations in our article, we did not show the photographs of the 
operative specimen and histologic findings in detail. On the 
macroscopic findings, the tumor filled the left lower pulmonary 
vein and was strongly attached to the wall of the pulmonary 
vein. Most of the intra-atrial tumor was free from the atrial wall 
and weakly attached to the atrial wall around the orifice of the 
pulmonary vein (Fig 1). Therefore, the tumor, the left lung, and 
the left side of the left atrial wall were excised en bloc. 
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Fig 1. A, Left pneumonectomy specimen with the tumor 
mass and the left atrial wall. B, Macroscopic finding of the 
left lower pulmonary vein and the tumor. The tumor is strongly 
attached to the wall of the pulmonary vein (arrow). 
Fig 2. Histologic findings at the portion of the tumor strongly 
attached to the vein wall. 
Histologic examination revealed that the tumor arose from the 
media of the pulmonary vein at the point where it was strongly 
attached (Fig 2). 
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Second, concerning surgical approach, they recommend a 
median sternotomy. We have used sternotomies in two cases 
of resected leiomyosarcoma originating in the left atrial walls 
close to the mitral anuli. In the reported case, the intra-atrial 
portion of the tumor was extremely large and filled most of 
the left atrium and the left lower pulmonary vein. Compared 
with our previous experiences, it seemed difficult to excise 
the tumor, the left atrial wall, and the left lung en bloc 
through a median sternotomy. Moreover, according to preop-
erative findings of computed tomography, magnetic reso-
nance imaging, cineangiography, and echocardiography, the 
tumor appeared to be attached to only the left wall of the atri-
um around the orifice of the lower pulmonary vein. Therefore 
we chose the left thoracotomy approach. If the tumor had 
been on the right side of the left atrium, we would have cho-
sen a median sternotomy as in the previous report. l Visuali-
zation of the remaining portion of the left atrial wall after 
resection of the tumor was good and the repair of the left atri-
um was very easy. Although it is not clear whether Babatasi 
and colleagues recommend a median sternotomy referring to 
their own experiences using both approaches, the surgical 
approach for this kind of lesion should be flexible, based on 
the preoperative findings of location and extension of the 
tumor. 
Finally, efficacy of chemotherapy and/or radiation after 
surgery is still controversial for primary sarcoma of lung.2-4 
Although multimodality treatments are used with some suc-
cess in advanced tumors, insufficient numbers of cases have 
been reported to confirm the benefit of adjuvant therapy after 
radical resection. At this moment, the two patients from our 
report are well and have no evidence of recurrence 30 months 
and 20 months after the operations, respectively. 
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The addition of saphenous vein graft to the left 
anterior descending artery in left internal thoracic 
artery hypoperfusion syndrome 
To the Editor: 
We read with interest the article on the surgical manage-
ment of the left internal thoracic artery (UTA) hypoperfu-
sion syndrome by Ziind and colleagues, published in the 
September 1997 issue of The Journal of Thoracic Cardio-
vascular Surgery.l We agree that the addition of a saphe-
nous vein graft (SVG) to the hypoperfused left anterior 
descending (LAD) artery territory despite UTA graft 
implantation is beneficial to the patient, especially in the 
acute phase. Although there was no mortality from the ITA 
hypoperfusion syndrome in this series, it is a serious condi-
tion that is potentially lethal,2,3 and reoperation is associat-
ed with increased morbidity.4 In our practice, the addition of 
an SVG to a hypoperfused LAD is performed during the 
original period of cardioplegic arrest (along with the other 
elective grafts) and before clinical signs of ITA hypoperfu-
sion syndrome occur. We implant an additional SVG to the 
LAD when the UTA is small and the flow is adequate but 
suboptimal. We are very pleased to note that the long-term 
flow rate of the UTA and SVG are satisfactory and there are 
no negative effects of one graft on the other, because we 
have not been able to carry out these measurements in our 
unit. The distance between the ITA graft and the suppple-
mental SVG was not discussed in this article, but recently it 
was shown that an increase in this distance improves the 
UTA graft survival.s We believe that our approach of pro-
phylactically adding an SVG to a potentially hypoperfused 
LAD territory is less traumatic to the patient and to the sur-
gical team. 
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